OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Therapeutic Approaches to the Treatment of Dyslipidemia 1: ApoC-III and ANGPTL3
Ji Yoon Kim, Nam Hoon Kim
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 1, pp. 23-23
Open Access | Times Cited: 9
Ji Yoon Kim, Nam Hoon Kim
Journal of Lipid and Atherosclerosis (2023) Vol. 12, Iss. 1, pp. 23-23
Open Access | Times Cited: 9
Showing 9 citing articles:
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4399-4399
Open Access | Times Cited: 28
The chylomicron saga: time to focus on postprandial metabolism
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 12
Alejandro Gugliucci
Frontiers in Endocrinology (2024) Vol. 14
Open Access | Times Cited: 12
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?
Dick C. Chan, Gerald F. Watts
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 101-109
Closed Access | Times Cited: 9
Dick C. Chan, Gerald F. Watts
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 101-109
Closed Access | Times Cited: 9
A Review of Progress on Targeting LDL Receptor-Dependent and -Independent Pathways for the Treatment of Hypercholesterolemia, a Major Risk Factor of ASCVD
Rai Ajit K. Srivastava
Cells (2023) Vol. 12, Iss. 12, pp. 1648-1648
Open Access | Times Cited: 16
Rai Ajit K. Srivastava
Cells (2023) Vol. 12, Iss. 12, pp. 1648-1648
Open Access | Times Cited: 16
THE ROLE OF THE ANGPTL3 PROTEIN IN LIPOPROTEIN METABOLISM AND ITS THERAPEUTIC POTENTIAL FOR DYSLIPIDEMIA
António Araújo, G. Smith Sobral Vieira, Elvis Pereira de Santana, et al.
International Journal of Health Science (2025) Vol. 3, Iss. 5, pp. 1-8
Closed Access
António Araújo, G. Smith Sobral Vieira, Elvis Pereira de Santana, et al.
International Journal of Health Science (2025) Vol. 3, Iss. 5, pp. 1-8
Closed Access
Journal of Lipid and Atherosclerosis in 2025: From Excellence to Eminence
In‐Kyung Jeong
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 1-1
Open Access
In‐Kyung Jeong
Journal of Lipid and Atherosclerosis (2025) Vol. 14, Iss. 1, pp. 1-1
Open Access
Angiopoietin-like Proteins and Lipoprotein Lipase: The Waltz Partners That Govern Triglyceride-Rich Lipoprotein Metabolism? Impact on Atherogenesis, Dietary Interventions, and Emerging Therapies
Alejandro Gugliucci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5229-5229
Open Access | Times Cited: 2
Alejandro Gugliucci
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5229-5229
Open Access | Times Cited: 2
Sugar and Dyslipidemia: A Double-Hit, Perfect Storm
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5660-5660
Open Access | Times Cited: 3
Alejandro Gugliucci
Journal of Clinical Medicine (2023) Vol. 12, Iss. 17, pp. 5660-5660
Open Access | Times Cited: 3
ICOSAPENT ETHYL AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN TYPE 2 DIABETES (NARRATIVE REVIEW)
Victoria Serhiyenko, Liudmyla Serhiyenko, Andriy Cherkas, et al.
Proceedings of the Shevchenko Scientific Society Medical Sciences (2023) Vol. 72, Iss. 2
Open Access
Victoria Serhiyenko, Liudmyla Serhiyenko, Andriy Cherkas, et al.
Proceedings of the Shevchenko Scientific Society Medical Sciences (2023) Vol. 72, Iss. 2
Open Access
